Scripted Launches in Pacific Northwest: Allowing Patients Convenient, Affordable, and Accessible Healthcare at Their Local Pharmacy
07 oct. 2021 10h15 HE | Scripted
CHICAGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Scripted (www.scripted.co) announced its new service to transform healthcare into an on-demand approach, where local pharmacists can prescribe and fill...
July 30, 2021 - ROSEN LOGO.jpg
ITRM NOTICE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ITRM
19 août 2021 14h15 HE | The Rosen Law Firm PA
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between November...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LONGSTANDING LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – ITRM
11 août 2021 19h45 HE | The Rosen Law Firm PA
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Iterum...
OpGen.jpg
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
27 juin 2019 07h30 HE | OpGen, Inc.
Collaborator data demonstrating OpGen’s rapid prediction of antibiotic resistance and detection of uropathogens presented at ASM Microbe 2019 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) --...
OpGen.jpg
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
13 juin 2019 07h30 HE | OpGen, Inc.
GAITHERSBURG, Md., June 13, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that data from its Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software will be presented at ASM...
OpGen.jpg
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
14 mai 2019 07h30 HE | OpGen, Inc.
GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has filed its 510(k) submission with the U.S. Food and Drug Administration (FDA) for clearance...
Cran-Max Effective Prevention in High Risk Cases of UTI
23 oct. 2013 15h21 HE | Cran-Max
KEARNY, NJ--(Marketwired - Oct 23, 2013) - Urinary tract infections (UTI) are responsible for more than 7 million doctor visits a year. Although UTIs can be treated in the short term with...
Cran-Max Better Option for Women Struggling With UTI
08 mars 2011 11h54 HE | Cran-Max
KEARNY, NJ--(Marketwire - March 8, 2011) - Each year, nearly 11 million women in the United States are given antibiotics for urinary tract infections (UTI). But a specific concentrated cranberry...
Birka Energi Year-End Report 2001
14 févr. 2002 04h38 HE | Birka Energi
STOCKHOLM, Sweden, Feb. 14, 2002 (PRIMEZONE) -- Birka Energi: -- Profit after financial items improved by close to 30 % compared with the previous year -- Continued substantial new sales of...